Table 2.
Correlations between NLR, PLR and PC and main clinicopathological variables for the 603 patients under study.
| No. of patients | H-NLR | H-PLR | H-PC | |
|---|---|---|---|---|
| Age | p = 0.026 | p = 0.747 | p = 0.398 | |
| ≤68.9 years | 299 | 66 (22.1%) | 19 (6.4%) | 79 (26.4%) |
| >68.9 years | 304 | 92 (30.3%) | 22 (7.2%) | 71 (23.4%) |
| Gender | p = 0.263 | p = 0.417 | p = 0.013 | |
| Male | 347 | 97 (28%) | 21 (6.1%) | 73 (21%) |
| Female | 256 | 61 (23.8%) | 20 (7.8%) | 77 (30.1%) |
| Tumour location | p = 1.000 | p = 0.280 | p = 0.006 | |
| Colon | 438 | 115 (26.3%) | 33 (7.5%) | 122 (27.9%) |
| Rectum | 165 | 43 (26.1%) | 8 (4.8%) | 28 (17%) |
| Depth of invasion (pT) | p < 0.001 | p = 0.023 | p < 0.001 | |
| pT1 | 77 | 7 (9.1%) | 0% | 8 (10.4%) |
| pT2 | 76 | 22 (28.9%) | 5 (6.6%) | 12 (15.8%) |
| pT3 | 270 | 63 (23.3%) | 16 (5.9%) | 70 (25.9%) |
| pT4a | 122 | 42 (34.4%) | 13 (10.7%) | 37 (30.3%) |
| pT4b | 58 | 24 (41.4%) | 7 (12.1%) | 23 (39.7%) |
| Node involvement (pN) | p = 0.679 | p = 0.374 | p = 0.172 | |
| pN0 | 380 | 95 (25%) | 26 (6.9%) | 88 (23.2%) |
| pN1 | 155 | 44 (28.4%) | 8 (5.2%) | 39 (25.2%) |
| pN2 | 68 | 19 (27.9%) | 7 (10.3%) | 23 (33.8%) |
| Systemic metastasis (M) | p < 0.001 | p = 0.059 | p = 0.101 | |
| M0 | 563 | 137 (24.3%) | 36 (6.4%) | 136 (24.2%) |
| M1a | 33 | 15 (45.5%) | 3 (9.1%) | 10 (30.3%) |
| M1b | 7 | 6 (85.7%) | 2 (28.1%) | 4 (57.1%) |
| AJCC/UICC TNM Stage | p < 0.001 | p = 0.106 | p = 0.008 | |
| Stage I | 130 | 27 (20.8%) | 5 (3.8%) | 18 (13.8%) |
| Stage II | 237 | 64 (27%) | 21 (8.9%) | 65 (27.4%) |
| Stage III | 196 | 46 (23.5%) | 10 (5.1%) | 53 (27%) |
| Stage IV | 40 | 21 (52.5%) | 5 (12.5%) | 14 (35%) |
| CEA serum levelb | p = 0.017 | p = 0.818 | p = 0.005 | |
| ≤5 ng/mL | 303 | 75 (24.8%) | 21 (6.9%) | 69 (22.8%) |
| >5 ng/mL | 92 | 35 (38%) | 7 (7.6%) | 35 (38%) |